S. Wax

发表

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial

A. Rajeswaran, S. Copt, E. Ginzler, 2012, Arthritis Research & Therapy.

Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus

D. Isenberg, P. Chang, D. Wallace, 2017, Arthritis & rheumatology.

Ongoing clinical trials and treatment options for patients with systemic sclerosis–associated interstitial lung disease

C. Denton, D. Khanna, D. Tashkin, 2018, Rheumatology.

Post Hoc Analysis of the Phase II/III APRIL‐SLE Study: Association Between Response to Atacicept and Serum Biomarkers Including BLyS and APRIL

C. Gordon, D. Isenberg, D. Wofsy, 2016, Arthritis & rheumatology.

University of Birmingham Post Hoc Analysis of the Phase II/III APRIL-SLE Study:

C. Gordon, D. Wofsy, S. Wax, 2016 .

Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over two years.

M. Hochberg, A. Guermazi, F. Roemer, 2020, Osteoarthritis and cartilage.

STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis–associated Interstitial Lung Disease

A. Wells, C. Denton, D. Khanna, 2020, The Journal of Rheumatology.

Advances in screening protocols for the detection of early bladder cancer.

R. Lew, H. Koh, D. Brooks, 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.

Felix Eckstein, Ali Guermazi, Marc C Hochberg, 2019, JAMA.

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial.

R. V. van Vollenhoven, J. Bathon, R. Vollenhoven, 2011, Arthritis and rheumatism.

Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases

E. Samy, P. Schneider, H. Hess, 2017, International reviews of immunology.

8 Efficacy and safety of atacicept in patients with systemic lupus erythematosus: results of a 24-week randomisedrandomized, placebo-controlled, phase iib study

D. Isenberg, P. Chang, P. Fraser, 2017, Lupus Science & Medicine.

Safety and Efficacy of Atacicept in Combination With Rituximab for Reducing the Signs and Symptoms of Rheumatoid Arthritis: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Pilot Trial

P. Tak, P. Tak, R. V. van Vollenhoven, 2015, Arthritis & rheumatology.

OP0059 Efficacy and safety of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomised, placebo-controlled, phase ii study

F. Eckstein, M. Hochberg, A. Guermazi, 2018, WEDNESDAY, 13 JUNE 2018.

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of Obexelimab in Systemic Lupus Erythematosus with Exploration of Response Based on Gene Pathway Co-Expression Patterns.

J. Guthridge, J. Merrill, J. James, 2023, Arthritis & rheumatology.